NSE BSE
amrutajan health ltd stock

AMRUTAJAN HEALTH LTD Share Price

- - (%)
Sector: -

17547

590006

AMRUTANJAN

img img img img
No Data Available

AMRUTAJAN HEALTH LTD Share Price Update


As of the latest trading session, AMRUTAJAN HEALTH LTD share price is currently at 742, which is down by -2.95 from its previous closing. Today, the stock has fluctuated between 737.30 and 755.00. Over the past year, AMRUTAJAN HEALTH LTD has achieved a return of 24.40 %. In the last month alone, the return has been 15.78 %.

AMRUTAJAN HEALTH LTD Performance

Day Range

Low737.30 High755.00
740.55

52 Week Range

Low 563.90 High 804.00
740.55

Open Price

744.95

Prev. Close

744.95

Volume (Shares)

4921.00

Total traded value

36.44

Upper Circuit

782.15

Lower Circuit

707.70

Note: The current prices & values are delayed, Login to your account for live updates.

AMRUTAJAN HEALTH LTD Fundamentals


(Standalone)

Market Cap (Cr) 1084.45
PE Ratio (TTM) 48.85
Book Value / Share 90.62
Beta 0.68
ROE 14.33%
EPS (TTM) 15.22
Dividend Yield 0.62%
Net Profit Qtr (Cr) 17.45

AMRUTAJAN HEALTH LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2023 (Values in Cr)
Revenue 116.99
Operating Expense 97.05
Net Profit 17.45
Net Profit Margin (%) 14.91
Earnings Per Share (EPS) 6.05
EBITDA 25.34
Effective Tax Rate (%) 26.40
Particulars SEP 2023 (Values in Cr)
Revenue 99.31
Operating Expense 94.05
Net Profit 6.85
Net Profit Margin (%) 6.89
Earnings Per Share (EPS) 2.36
EBITDA 10.79
Effective Tax Rate (%) 25.62
Particulars JUN 2023 (Values in Cr)
Revenue 77.86
Operating Expense 72.11
Net Profit 7.01
Net Profit Margin (%) 9.00
Earnings Per Share (EPS) 2.40
EBITDA 10.84
Effective Tax Rate (%) 25.55
Particulars MAR 2023 (Values in Cr)
Revenue 100.32
Operating Expense 88.67
Net Profit 12.70
Net Profit Margin (%) 12.65
Earnings Per Share (EPS) 4.35
EBITDA 17.79
Effective Tax Rate (%) 22.95
Particulars DEC 2022 (Values in Cr)
Revenue 97.65
Operating Expense 86.82
Net Profit 10.71
Net Profit Margin (%) 10.96
Earnings Per Share (EPS) 3.67
EBITDA 15.83
Effective Tax Rate (%) 26.13
Particulars MAR 2023 (Values in Cr)
Revenue 379.64
Operating Expense 340.53
Net Profit 39.83
Net Profit Margin (%) 10.49
Earnings Per Share (EPS) 13.65
EBITDA 58.94
Effective Tax Rate (%) 25.74
Particulars MAR 2022 (Values in Cr)
Revenue 405.84
Operating Expense 330.64
Net Profit 67.19
Net Profit Margin (%) 16.55
Earnings Per Share (EPS) 23.05
EBITDA 94.86
Effective Tax Rate (%) 25.82
Particulars MAR 2021 (Values in Cr)
Revenue 332.84
Operating Expense 262.26
Net Profit 61.19
Net Profit Margin (%) 18.38
Earnings Per Share (EPS) 20.94
EBITDA 86.07
Effective Tax Rate (%) 25.28
Particulars MAR 2020 (Values in Cr)
Revenue 261.48
Operating Expense 235.34
Net Profit 25.08
Net Profit Margin (%) 9.59
Earnings Per Share (EPS) 8.58
EBITDA 39.03
Effective Tax Rate (%) 27.19
Particulars MAR 2019 (Values in Cr)
Revenue 253.23
Operating Expense 225.19
Net Profit 24.51
Net Profit Margin (%) 9.67
Earnings Per Share (EPS) 8.38
EBITDA 38.41
Effective Tax Rate (%) 28.91
Particulars MAR 2016 (Values in Cr)
Book Value / Share 74.40
ROE % 20.21
ROCE % 31.43
Total Debt to Total Equity 0.02
EBITDA Margin 18.63
Particulars MAR 2015 (Values in Cr)
Book Value / Share 64.97
ROE % 16.18
ROCE % 25.28
Total Debt to Total Equity 0.06
EBITDA Margin 16.05
Particulars MAR 2014 (Values in Cr)
Book Value / Share 61.06
ROE % 14.51
ROCE % 21.52
Total Debt to Total Equity 0.13
EBITDA Margin 16.64
Particulars MAR 2013 (Values in Cr)
Book Value / Share 56.29
ROE % 12.69
ROCE % 18.14
Total Debt to Total Equity 0.23
EBITDA Margin 14.95
Particulars MAR 2012 (Values in Cr)
Book Value / Share 264.62
ROE % 10.78
ROCE % 16.36
Total Debt to Total Equity 0.29
EBITDA Margin 14.94
Particulars MAR 2023 (Values in Cr)
Book Value / Share 99.47
ROE % 14.33
ROCE % 18.81
Total Debt to Total Equity 0.00
EBITDA Margin 15.56
Particulars MAR 2022 (Values in Cr)
Book Value / Share 90.70
ROE % 27.96
ROCE % 36.78
Total Debt to Total Equity 0.00
EBITDA Margin 23.40
Particulars MAR 2021 (Values in Cr)
Book Value / Share 73.75
ROE % 32.64
ROCE % 42.34
Total Debt to Total Equity 0.01
EBITDA Margin 25.89
Particulars MAR 2020 (Values in Cr)
Book Value / Share 54.54
ROE % 16.44
ROCE % 21.86
Total Debt to Total Equity 0.01
EBITDA Margin 14.97
Particulars MAR 2019 (Values in Cr)
Book Value / Share 49.86
ROE % 17.87
ROCE % 24.45
Total Debt to Total Equity 0.00
EBITDA Margin 15.02
Particulars MAR 2016 (Values in Cr)
Cash & Short Term Investments 48.24
Total Assets 140.43
Total Liabilities 140.43
Total Equity 108.74
Share Outstanding 14615315
Price to Book Ratio 5.06
Return on Assets (%) 14.65
Return on Capital (%) 18.5
Particulars MAR 2015 (Values in Cr)
Cash & Short Term Investments 37.88
Total Assets 123.90
Total Liabilities 123.90
Total Equity 94.95
Share Outstanding 14615315
Price to Book Ratio 6.67
Return on Assets (%) 12.02
Return on Capital (%) 15.29
Particulars MAR 2014 (Values in Cr)
Cash & Short Term Investments 35.20
Total Assets 120.26
Total Liabilities 120.26
Total Equity 89.23
Share Outstanding 14615315
Price to Book Ratio 1.89
Return on Assets (%) 10.34
Return on Capital (%) 12.8
Particulars MAR 2013 (Values in Cr)
Cash & Short Term Investments 14.90
Total Assets 124.15
Total Liabilities 124.15
Total Equity 82.26
Share Outstanding 14615315
Price to Book Ratio 1.93
Return on Assets (%) 8.14
Return on Capital (%) 10.4
Particulars MAR 2012 (Values in Cr)
Cash & Short Term Investments 15.23
Total Assets 124.20
Total Liabilities 124.20
Total Equity 77.26
Share Outstanding 2923063
Price to Book Ratio 2.77
Return on Assets (%) 7.75
Return on Capital (%) 9.9
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 70.31
Total Assets 362.09
Total Liabilities 362.09
Total Equity 290.77
Share Outstanding 29230630
Price to Book Ratio 5.78
Return on Assets (%) 11.00
Return on Capital (%) 13.7
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 87.75
Total Assets 349.86
Total Liabilities 349.86
Total Equity 265.12
Share Outstanding 29230630
Price to Book Ratio 8.75
Return on Assets (%) 19.20
Return on Capital (%) 25.34
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 139.31
Total Assets 274.27
Total Liabilities 274.27
Total Equity 215.56
Share Outstanding 29230630
Price to Book Ratio 7.71
Return on Assets (%) 22.31
Return on Capital (%) 28.39
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 36.32
Total Assets 205.34
Total Liabilities 205.34
Total Equity 159.42
Share Outstanding 29230630
Price to Book Ratio 6.05
Return on Assets (%) 12.21
Return on Capital (%) 15.73
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 81.30
Total Assets 187.61
Total Liabilities 187.61
Total Equity 145.73
Share Outstanding 29230630
Price to Book Ratio 6.23
Return on Assets (%) 13.06
Return on Capital (%) 16.82
Particulars MAR 2016 (Values in Cr)
Net Income 32.68
Cash from Operations 32.18
Cash from Investing 4.16
Cash from Financing -13.10
Net change in Cash 11.75
Free Cash Flow 34.38
Particulars MAR 2015 (Values in Cr)
Net Income 24.14
Cash from Operations 27.69
Cash from Investing -4.89
Cash from Financing -11.92
Net change in Cash 1.49
Free Cash Flow 33.49
Particulars MAR 2023 (Values in Cr)
Net Income 53.64
Cash from Operations 36.24
Cash from Investing -2.47
Cash from Financing -14.98
Net change in Cash 2.71
Free Cash Flow 45.17
Particulars MAR 2022 (Values in Cr)
Net Income 90.57
Cash from Operations 76.38
Cash from Investing -36.21
Cash from Financing -16.70
Net change in Cash -0.71
Free Cash Flow 99.85
Particulars MAR 2021 (Values in Cr)
Net Income 81.90
Cash from Operations 109.56
Cash from Investing -87.76
Cash from Financing -7.42
Net change in Cash -4.31
Free Cash Flow 109.56
Particulars MAR 2020 (Values in Cr)
Net Income 34.45
Cash from Operations 29.32
Cash from Investing -13.85
Cash from Financing -11.68
Net change in Cash -7.36
Free Cash Flow 29.32
Particulars MAR 2019 (Values in Cr)
Net Income 34.68
Cash from Operations 31.34
Cash from Investing -11.01
Cash from Financing -6.95
Net change in Cash 3.20
Free Cash Flow 31.34
Company Name Price P/E P/B Market Cap 52 Week Low/High
BLISS GVS PHARMA LTD 109.55 11.97 1.18 1146.89 71.00 / 148.95
CIPLA LTD 1399.35 26.53 4.23 112982.81 911.80 / 1519.00
FERMENTA BIOTECH LIMITED 161.20 0.00 1.65 474.43 132.30 / 214.00
GLAXOSMITHKLINE PHARMA LT 2291.55 56.12 21.83 38820.24 1265.00 / 2649.95
SANOFI INDIA LIMITED 8857.55 35.96 20.09 20398.94 6253.40 / 9370.35
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMRUTAJAN HEALTH LTD 743.50 48.85 8.20 2149.51 556.05 / 802.60
ASTRAZENECA PHARMA IND LT 5757.75 90.25 21.97 14394.38 3131.10 / 7208.00
BLISS GVS PHARMA LTD 109.55 15.13 1.16 1146.89 71.00 / 148.95
ABBOTT INDIA LIMITED 26490.20 46.86 15.21 56291.68 20594.25 / 29628.15
CIPLA LTD 1399.35 30.42 4.03 112982.81 911.80 / 1519.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 746.50
  • 26 Days 720.80
  • 10 Days 751.00
  • 50 Days 693.50
  • 12 Days 742.50
  • 100 Days 656.70
  • 20 Days 725.30
  • 200 Days 647.70
749.62
PIVOT
First Resistance 756.18
Second Resistance 762.57
Third Resistance 769.13
First Support 743.23
Second Support 736.67
Third Support 730.28
RSI 61.58
MACD 21.74
Commodity Channel Index (CCI) 46.47
ADX 40.38
Williams % R -50.04

Over 1 Month

down

15.78

Over 3 Months

down

14.42

Over 6 Months

down

23.10

Over 1 Year

down

24.40

Over 3 Years

down

1.00

Over 5 Years

down

21.66

AMRUTAJAN HEALTH LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

AMRUTAJAN HEALTH LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
41.24
Promoter Holdings
50.58
FII
1.37
DII
6.79
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Goodhealth Holdings Private Limited Shareholding of Promoter and Promoter Group 5825803.0 20.15
Sambhuprasad Sivalenka Shareholding of Promoter and Promoter Group 2990730.0 10.34
Sathyanarayana Murthi Pasumarthi Shareholding of Promoter and Promoter Group 2508000.0 8.68
Dsp Small Cap Fund Public Shareholding 1466269.0 5.07
Sambhu Prasad Sivalenka Shareholding of Promoter and Promoter Group 1040171.0 3.6
Ramaa P Arikirevula Shareholding of Promoter and Promoter Group 872535.0 3.02
Ramalingam Ganti Shareholding of Promoter and Promoter Group 730640.0 2.53
Amulya Kamakshi Priya Arikirevula Shareholding of Promoter and Promoter Group 616781.0 2.13
Sundaram Mutual Fund A/c Sundaram Small Cap Fund Public Shareholding 484538.0 1.68
Rajashekar Iyer Public Shareholding 479150.0 1.66
Dipak Kanayalal Shah Public Shareholding 307000.0 1.06
Pasumarthi Sathyanarayana Murthi Shareholding of Promoter and Promoter Group 36530.0 0.13
Nageswara Rao Shareholding of Promoter and Promoter Group 4420.0 0.02

AMRUTAJAN HEALTH LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2024-02-20 1.0 Interim 2 2024-02-20 Equity shares 2023-11-23 1.0 Interim 1 2023-11-23 Equity shares 2023-09-14 2.6 Final 2023-09-14 Equity shares 2023-02-24 1.0 Interim 2 2023-02-24 Equity shares 2022-11-14 1.0 Interim 1 2022-11-15 Equity shares 2022-09-14 2.6 Final 2022-09-16 Equity shares 2022-02-18 1.0 Interim 2 2022-02-21 Equity shares 2021-11-16 1.0 Interim 1 2021-11-17 Equity shares 2021-09-15 2.6 Final 2021-09-16 Equity shares 2021-02-17 0.8 Interim 2 2021-02-19 Equity shares 2020-11-19 0.8 Interim 1 2020-11-20 Equity shares 2020-02-18 1.55 Interim 2 2020-02-21 Equity shares 2019-11-15 0.55 Interim 1 2019-11-18 Equity shares 2019-09-17 1.05 Final 2019-09-19 Equity shares 2019-02-20 0.55 Interim 2 2019-02-21 Equity shares 2018-11-12 0.55 Interim 1 2018-11-13 Equity shares 2018-09-07 0.85 Final 2018-09-11 Equity shares 2018-02-22 1.1 Interim 2 2018-02-23 Equity shares 2017-11-16 1.1 Interim 1 2017-11-17 Equity shares 2017-09-13 1.65 Final 2017-09-14 Equity shares 2017-02-16 1.1 Interim 2 2017-02-17 Equity shares 2016-11-17 1.1 Interim 1 2016-11-18 Equity shares 2016-03-18 2.65 Interim 2 2016-03-21 Equity shares 2016-02-17 1.2 Interim 2016-02-19 Equity shares 2015-09-10 2.4 Final 2015-09-12 Equity shares 2015-02-13 1.1 Interim 2015-02-17 Equity shares 2014-09-17 2.2 Final 2014-09-19 Equity shares 2014-02-17 1.0 Interim 2014-02-19 Equity shares 2013-08-02 2.0 Final 2013-08-06 Equity shares 2013-02-21 1.0 Interim 2013-02-22 Equity shares 2012-09-20 10.0 Final 2012-09-24 Equity shares 2012-02-23 5.0 Interim 2012-02-24 Equity shares 2011-09-12 10.0 Final 2011-09-14 Equity shares 2011-02-21 5.0 Interim 2011-02-22 Equity shares 2010-08-13 10.0 Final 2010-08-17 Equity shares 2010-02-09 5.0 Interim 2010-02-10 Equity shares 2009-09-16 12.0 Final 2009-09-18 Equity shares 2009-02-04 5.0 Interim 2009-02-05 Equity shares 2008-09-08 3.0 Final 2008-09-10 Equity shares 2008-07-28 40.0 Interim 2008-07-29 Equity shares 2008-02-05 4.0 Interim 2008-02-06 Equity shares 2007-08-03 2.0 Final 2007-08-07 Equity shares 2007-01-24 4.0 Interim 2007-01-25 Equity shares 2005-07-29 0.0 Final 2005-08-02 Equity shares 2005-02-14 0.0 Interim 2005-02-15 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date
2018-04-13 2.0 1.0 2018-04-16 2012-10-25 10.0 2.0 2012-10-29

Learn More About Stocks

About AMRUTAJAN HEALTH LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by AMRUTAJAN HEALTH LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Amrutanjan Health Care Ltd?

Answer Field

The share price of Amrutanjan Health Care Ltd for NSE is ₹ 742 and for BSE is ₹ 743.35.

What is the Market Cap of Amrutanjan Health Care Ltd?

Answer Field

The market cap of Amrutanjan Health Care Ltd for NSE is ₹ 1,084.45 Cr. and for BSE is ₹ 1,086.42 Cr. as of now.

What is the 52 Week High and Low of Amrutanjan Health Care Ltd?

Answer Field

The 52 Week High and Low of Amrutanjan Health Care Ltd for NSE is ₹ 804.00 and ₹ 563.90 and for BSE is ₹ 802.60 and ₹ 556.05.

How to Buy Amrutanjan Health Care Ltd share?

Answer Field

You can trade in Amrutanjan Health Care Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Amrutanjan Health Care Ltd?

Answer Field

The 1 year returns on the stock has been 24.40%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text
loader